Lv3
290 积分 2022-11-24 加入
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
2天前
已完结
Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial
3天前
已完结
Sciatica
14天前
已完结
Pneumonia
18天前
已完结
Neuropathic pain
1个月前
已完结
Chronic pain: an update on burden, best practices, and new advances
1个月前
已完结
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double‐blind, multicenter study
2个月前
已完结
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
3个月前
已完结
Elagolix Treatment for Endometriosis-Associated Pain: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
4个月前
已完结
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
6个月前
已完结
皖公网安备34019202002308
